HKD 0.16
(8.39%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 61.8 Million HKD | 20.21% |
2022 | 51.41 Million HKD | -51.15% |
2021 | 105.25 Million HKD | 32.1% |
2020 | 79.67 Million HKD | 2.44% |
2019 | 77.77 Million HKD | 46.15% |
2018 | 53.21 Million HKD | -18.22% |
2017 | 65.07 Million HKD | 25.02% |
2016 | 52.05 Million HKD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q2 | 67.09 Million HKD | 30.49% |
2023 FY | 61.8 Million HKD | 20.21% |
2023 Q4 | 61.8 Million HKD | -7.88% |
2022 Q4 | 51.41 Million HKD | -31.92% |
2022 FY | 51.41 Million HKD | -51.15% |
2022 Q2 | 75.51 Million HKD | -28.25% |
2021 Q2 | 118.97 Million HKD | 49.32% |
2021 FY | 105.25 Million HKD | 32.1% |
2021 Q4 | 105.25 Million HKD | -11.53% |
2020 Q2 | 121.17 Million HKD | 55.79% |
2020 FY | 79.67 Million HKD | 2.44% |
2020 Q4 | 79.67 Million HKD | -34.24% |
2019 Q4 | 77.77 Million HKD | 0.0% |
2019 FY | 77.77 Million HKD | 46.15% |
2018 FY | 53.21 Million HKD | -18.22% |
2017 FY | 65.07 Million HKD | 25.02% |
2016 FY | 52.05 Million HKD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 308.05 Million HKD | 79.937% |
Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | 94.189% |
China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | 43.351% |
Prosperous Future Holdings Limited | 177.1 Million HKD | 65.103% |
Huasheng International Holding Limited | 675.58 Million HKD | 90.852% |
Evergreen Products Group Limited | 786.46 Million HKD | 92.141% |
EC Healthcare | 2.97 Billion HKD | 97.919% |
Ming Fai International Holdings Limited | 772.01 Million HKD | 91.994% |
Blue Moon Group Holdings Limited | 1.61 Billion HKD | 96.18% |
SuperRobotics Holdings Limited | 172.27 Million HKD | 64.124% |
Takbo Group Holdings Limited | 42.84 Million HKD | -44.239% |
Hyfusin Group Holdings Limited | 181.34 Million HKD | 65.919% |